Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
clinical trials
eli lilly
2
×
fda
2
×
indiana blog main
indiana top stories
life sciences
national blog main
raleigh-durham blog main
2
×
raleigh-durham top stories
10x genomics
abbvie
allergan
alprazolam
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
cgrp inhibitors
chinook therapeutics
chronic migraine
clostridium difficile
colucid pharmaceuticals
community-acquired bacterial pneumonia
dana hilt
daprodustat
david chacko
What
fda
won
acute
addresses
approval
august
bio
biotech
busy
causes
condition
days
decades
decisions
devices
drug
drugs
eli
friday
giant
giving
lasmiditan
legacy
lilly
lilly’s
medication
migraine
new
news
nods
oks
opioid
past
pharmaceutical
regulatory
roundup
sarepta’s
second
seven
shkreli’s
Language
unset
2
×
Current search:
won���t
×
unset
×
" eli lilly "
×
fda
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
